Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

p53 immunocytochemistry and TP53 gene mutations in patients with chronic hepatitis C virus (HCV) infection.

Folia histochemica et cytobiologica - 1 Jan 2009

Kasprzak Aldona, Adamek Agnieszka, Przybyszewska Wiesława, Czajka Arkadiusz, Olejniczak Karolina, Juszczyk Jacek, Biczysko Wiesława, Zabel Maciej

Abstract excerpt

Chronic infection with hepatitis C virus (HCV) is regarded as a risk factor for hepatocellular carcinoma (HCC), mostly in patients with liver cirrhosis. Present study aimed at evaluation of cellular expression of p53 protein, genetic TP53 changes in liver samples and anti-p53 in serum of patients with chronic hepatitis C virus infection. The expression of p53 protein were analysed by immunocytochemistry in liver...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Exons
Share to Hepacivirus

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Hepatitis C, Chronic

Share to Hepatocytes

Share to Immunohistochemistry

Share to Polymorphism, Single-Stranded Conformational

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 19419935
DOI: 10.2478/v10042-009-0003-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

p53 immunocytochemistry and TP53 gene mutations in patients with chronic hepatitis C virus (HCV) infection.PMID 19419935Read ↗

Liver p53 expression in patients with HCV-related chronic hepatitis.Semantic proximity Read ↗

p53 expression in patients with cirrhosis with and without hepatocellular carcinoma.Semantic proximity Read ↗

Molecular characterization of p53 mutations in primary and secondary liver tumors: diagnostic and therapeutic perspectives.Semantic proximity Read ↗

Human TP53 gene polymorphisms among patients with Hepatocellular carcinoma and chronic hepatitis B infection in KenyaSemantic proximity Read ↗

The p53 mutation spectrum in hepatocellular carcinoma from Guangxi, China : role of chronic hepatitis B virus infection and aflatoxin B1 exposure.Semantic proximity Read ↗

A comparative study of P53/MDM2 genes alterations and P53/MDM2 proteins immunoreactivity in liver cirrhosis and hepatocellular carcinoma.Semantic proximity Read ↗

Comparative Studies on Tumor Protein 53 Gene Polymorphism, Demographic Attributes and Associated Risk Factors Among Hepatocellular Carcinoma and Liver Cirrhosis Patients in Calabar, NigeriaSemantic proximity Read ↗

Clinical significance of aflatoxin, mutant P53 gene and sIL-2 receptor in liver cirrhosis and hepatocellular carcinoma.Semantic proximity Read ↗

p53 mutation in HCV-genotype-4 associated hepatocellular carcinoma in Egyptian patients.Semantic proximity Read ↗

P53 codon 249 mutation in hepatocellular carcinomas from Nigeria.Semantic proximity Read ↗

Mutational hotspot in the p53 gene in human hepatocellular carcinomas.Semantic proximity Read ↗

p53 protein accumulation in European hepatocellular carcinoma is not always dependent on p53 gene mutation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.